Skip to main content
. 2020 May 13;16(12):3131–3137. doi: 10.1080/21645515.2020.1752595

Table 4.

Pre-questionnaire only

Question(s) N (%) of answers pre-Q
Did you hear of human papillomavirus (HPV) before today?d
Total participants (N) 120
Yes 116 (94.3)
No 3 (2.4)
I don’t know 1 (0.8)
I currently discuss the connection between HPV and oropharyngeal cancer with my patients or their parents?d
Total participants (N) 117
No, and I do not intend to start 17 (14.5)
No, but I have considered it 65 (55.6)
Yes, but only with some patients 19 (16.2)
Yes, with all or most (75% or more) of my patients 3 (2.6)
Other (please specify): 13 (11.1)
Why do you not currently discuss the connection between HPV and oropharyngeal cancer with your patients? (Select all that apply.)d
Total participants (N) 117
I don’t have enough information 69 (59.0)
Practice setting is not sufficiently private 31 (26.5)
Discomfort discussing sexual history with my patients 23 (19.7)
No professional policies/guidelines 23 (19.7)
I cannot provide an HPV vaccine to my patients 14 (12.0)
Appointments not long enough 12 (10.3)
I discuss the connection between HPV and oropharyngeal cancer with my patients 8 (6.8)
Other (please specify): 8 (6.8)
Not my role as oral health provider 7 (5.9)
Liability Reasons 7 (5.9)
Concern with safety of vaccine 3 (2.6)
Which of the following tools for increasing education and acceptance of HPV vaccination are most useful to you? (Select all that apply.)d
Total participants (N) 117
Informational flyers or brochures tailored to specific parental concerns 88 (75.2)
Education for oral health professionals regarding HPV 75 (64.1)
Discussion guide or health script for oral health professionals 65 (55.6)
Information catered to cultural or ethical preferences 55 (47.0)
Information for parents provided before clinic visit 48 (41.0)
Other (please specify) 3 (2.6)
None 0 (0.0)
At your facility have you received education/trainings about HPV?d
Total participants (N) 117
Yes 19 (16.2)
No 89 (76.1)
I don’t know 9 (7.7)
If training could be provided, what format of training would be beneficial to your facility? (Select all that apply.)d
Total participants (N) 117
In person 75 (64.1)
Webinar 72 (61.5)
Online self-study 38 (32.5)
Offline self-study 9 (7.7)
Other (please specify): 2 (1.7)

d Denotes questions used to assess OHP’s self-reported facilitators and barriers in HPV prevention.